Free Trial

Capricor Therapeutics (CAPR) SEC Filings & 10K Form

Capricor Therapeutics logo
$18.92 +0.46 (+2.49%)
(As of 11/20/2024 ET)

Recent Capricor Therapeutics SEC Filings

DateFilerForm TypeView
11/13/2024
3:02 PM
Capricor Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2024
10:46 AM
BlackRock, Inc. (Filed by)
Capricor Therapeutics (Subject)
Form SC 13G
11/08/2024
8:00 AM
Capricor Therapeutics (Subject)
HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by)
Form SC 13G/A
10/24/2024
1:02 PM
BlackRock, Inc. (Filed by)
Capricor Therapeutics (Subject)
Form SC 13G
10/22/2024
4:11 PM
Capricor Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
10/17/2024
3:15 PM
Capricor Therapeutics (Filer)
Form 424B5
10/16/2024
11:15 PM
Capricor Therapeutics (Filer)
Form EFFECT
10/17/2024
5:01 AM
Capricor Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2024
3:25 PM
Capricor Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2024
3:35 PM
Capricor Therapeutics (Filer)
Form 424B5
10/16/2024
12:31 PM
Capricor Therapeutics (Filer)
Form S-3/A
10/09/2024
8:16 AM
Capricor Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/24/2024
3:03 PM
Capricor Therapeutics (Subject)
Nippon Shinyaku Co Ltd (Filed by)
Form SC 13G/A
09/24/2024
3:01 PM
Capricor Therapeutics (Issuer)
Nippon Shinyaku Co Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/24/2024
3:01 PM
Capricor Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2024
8:15 AM
Capricor Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2024
8:00 AM
Capricor Therapeutics (Issuer)
Musket David B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
4:00 PM
Capricor Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/14/2024
3:31 PM
Capricor Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
05/15/2024
4:00 PM
Capricor Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
8:00 AM
Capricor Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2024
8:25 AM
Capricor Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2024
8:15 AM
Capricor Therapeutics (Issuer)
COLLIER EARL M JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2024
12:30 PM
Capricor Therapeutics (Issuer)
Musket David B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
3:31 PM
Capricor Therapeutics (Filer)
Form ARS
03/20/2024
4:20 PM
Capricor Therapeutics (Filer)
Form PRE 14A
03/11/2024
7:30 AM
Capricor Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/29/2024
3:06 PM
Capricor Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2024
2:01 PM
Capricor Therapeutics (Subject)
HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by)
Form SC 13G
01/11/2024
8:00 AM
Capricor Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2024
4:15 PM
Bergmann Anthony (Reporting)
Capricor Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
4:15 PM
Capricor Therapeutics (Issuer)
Krasney Karen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
4:15 PM
Capricor Therapeutics (Issuer)
Marban Linda (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
4:15 PM
Capricor Therapeutics (Issuer)
Litvack Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
4:15 PM
Capricor Therapeutics (Issuer)
COLLIER EARL M JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
4:15 PM
Capricor Therapeutics (Issuer)
Sabar Karimah Es (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
4:15 PM
Capricor Therapeutics (Issuer)
DUNBAR GEORGE W JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
4:15 PM
Capricor Therapeutics (Issuer)
Musket David B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
4:15 PM
Auwaerter Paul Gisbert (Reporting)
Capricor Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
4:15 PM
Capricor Therapeutics (Issuer)
Gotwals Philip J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
4:15 PM
Capricor Therapeutics (Issuer)
Kelliher Mike (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
2025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad)

The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.

👉[Click here to get your FREE report delivered instantly!]
12/11/2023
3:30 PM
Capricor Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CAPR) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners